Last reviewed · How we verify
Walnuts
Walnuts is a Small molecule drug developed by University of California, San Francisco. It is currently in Phase 1 development.
-
Baseline phase 1 → approval rate
+9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2033–2036 | — |
| EMA | EU | 2034–2037 | +0.7 yr |
| MHRA | GB | 2034–2037 | +0.7 yr |
| Health Canada | CA | 2034–2038 | +0.9 yr |
| TGA | AU | 2034–2038 | +1.2 yr |
| PMDA | JP | 2034–2038 | +1.5 yr |
| NMPA | CN | 2035–2039 | +2.3 yr |
| MFDS | KR | 2034–2038 | +1.4 yr |
| CDSCO | IN | 2034–2039 | +1.8 yr |
| ANVISA | BR | 2035–2039 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Walnuts |
|---|---|
| Sponsor | University of California, San Francisco |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Snacking Effects on the Brain Response to Foods and Satiety During Dieting (NA)
- Nut Consumption and Prevention of Non-communicable Diseases: A Global Individual Participant Data Meta-analysis
- Effect of Walnuts on Sperm Parameters and Male Fertility (NA)
- Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy (PHASE2)
- Effect of Daily Walnut Consumption on Memory in Subjects With Long-COVID (NA)
- Long-Term Effects of Walnut Consumption on Brain Function (NA)
- The TreEat Study- Can Early Introduction of Tree Nuts Prevent Tree Nut Allergy in Infants With Peanut Allergy (PHASE3)
- A Phase 1 Study of Cizutamig in IgE Mediated Diseases (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Walnuts CI brief — competitive landscape report
- Walnuts updates RSS · CI watch RSS
- University of California, San Francisco portfolio CI
Frequently asked questions about Walnuts
What is Walnuts?
Who makes Walnuts?
What development phase is Walnuts in?
Related
- Manufacturer: University of California, San Francisco — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing